Industry News
Australian biotech market watch 01/07/09
Cochlear, Ramsay, ResMed, Biota, Ansell [ + ]
Minicells defeat drug resistant cancer
Australian researchers find that interfering RNA delivered via bacterially-derived minicells can target and kill drug resistant tumours. [ + ]
Patrys Announces $6.8 Million Rights Issue
Patrys Limited (ASX:PAB) announces a renounceable pro-rata rights issue to eligible shareholders. [ + ]
UQ generates first Australian swine flu vaccine
The University of Queensland's Australian Institute for Bioengineering and Nanotechnology has created a vaccine matched to the virus found in the first US case of swine flu.
[ + ]Junk no more - RNAs get networking
New technology is allowing us to probe the dark matter of the genome, providing further evidence for John Mattick’s no-longer controversial argument that much of the genome, previously thought to be junk DNA, actually codes for a vast network of regulatory RNAs. [ + ]
Australian biotech market watch 26/06/09
ResMed, CSL, Biota, Sonic Healthcare, ChemGenex, Sirtex [ + ]
Stem cell's genetic surprise
Adult muscle stem cells rather than embryonic stem cells could be the key to treating muscular disorders. [ + ]
Bionomics commences clinical trial
Anti-anxiety drug, BNC210, to undergo phase I clinical trial in Adelaide. [ + ]
Diabetes biomarker discovered
Hormone adiponectin could be used to better diagnose and treat type 2 diabetes. [ + ]
Xenotransplantation trial to commence in NZ
Calls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here. [ + ]
Australian biotech market watch 23/06/09
COH, CSL, RHC, ANN, SRX [ + ]
Sniffing out cancer
Researchers have been able to differentiate not only between healthy and cancerous cells but also between metastatic and non-metastatic cancer cells using an array of nanoparticles and polymers.
[ + ]Phosphagenics signs agreement with CSL
CSL to evaluate Phosphagenics' TMP technology with the possibility of an expanded collaboration in the future. [ + ]
Amarillo progresses interferon trial in WA
Screening process completed for phase II clinical trial of interferon to treat influenza. [ + ]
Australian biotech market watch 19/06/09
CSL, COH, ANN, BKL, NRT [ + ]